Imaging-Detected Extranodal Extension in Head and Neck Cancer: Current Evidence, Standardized Grading, and Clinical Implications

Extranodal extension (ENE) of metastatic lymph nodes is a well-established adverse prognostic factor in head and neck cancer and has traditionally been confirmed pathologically.Imaging-detected ENE (iENE) enables pre-treatment assessment and provides prognostic information across different treatment settings.Recent studies and meta-analyses have demonstrated an independent association between iENE and adverse outcomes in both nasopharyngeal carcinoma (NPC) and human papillomavirus-positive oropharyngeal carcinoma, supporting its prognostic relevance, particularly in nonsurgical patient populations in whom pathological confirmation is unavailable.Growing evidence supporting the prognostic impact of iENE has influenced recent revisions to the American Joint Committee on Cancer 9th edition staging system, which now incorporates "advanced radiological ENE" as a criterion for the N3 category in NPC.However, the clinical interpretation of iENE remains constrained by substantial interobserver variability, heterogeneous imaging criteria, and an imperfect correlation with pathological ENE (pENE), underscoring the ongoing debate regarding its clinical validity.Recent international efforts have sought to standardize imaging definitions and grading systems for iENE, with the aim of reducing variability and facilitating more consistent application in clinical practice and research.This review summarizes the current evidence regarding the prognostic and diagnostic roles of iENE, outlines recent developments in its classification, and discusses future directions for its integration into risk-adapted treatment planning for head and neck cancer.